Clinical trial
Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Seizure Activity in Pediatric Patients With Epilepsy
NCT00326612 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Seizure Activity in Pediatric Patients With Epilepsy
- Lead sponsor
- University of Utah
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- December 31, 2008
- Enrollment
- 358 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.